Lonza Group AG
LONN
株式のランク
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
株価
$764.04
時価総額
$53.36B
変化（1日）
0.96%
変化（1年）
8.59%
国
CH
取引 Lonza Group AG (LONN)
カテゴリー
Healthcare
Lonza Group AG（LONN）の収益
Oct 2026 時点の収益 TTM: 0
Lonza Group AG の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Lonza Group AG の収益履歴（2004 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2025 | $8.23B | 35.66% |
| 2024 | $6.07B | -24.04% |
| 2023 | $7.99B | 18.66% |
| 2022 | $6.73B | 13.45% |
| 2021 | $5.93B | 18.22% |
| 2020 | $5.02B | 15.40% |
| 2019 | $4.35B | -22.81% |
| 2018 | $5.63B | 20.73% |
| 2017 | $4.67B | 14.94% |
| 2016 | $4.06B | 6.70% |
| 2015 | $3.80B | 3.83% |
| 2014 | $3.66B | -8.77% |
| 2013 | $4.02B | -6.34% |
| 2012 | $4.29B | 49.65% |
| 2011 | $2.87B | -0.07% |
| 2010 | $2.87B | 10.16% |
| 2009 | $2.60B | -5.33% |
| 2008 | $2.75B | 8.28% |
| 2007 | $2.54B | 35.49% |
| 2006 | $1.87B | 30.23% |
| 2005 | $1.44B | -25.02% |
| 2004 | $1.92B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| $10.11B | - |
BE
|
